RegulatoryCNBC-TV18
Alkem Laboratories gets USFDA warning letter with OAI classification for Daman facility
Negative-64
GreyOak summary
Alkem Laboratories received a USFDA warning letter regarding its Daman facility after an inspection. The company stated it will take corrective actions but continues manufacturing.
What it affects
- Alkem LaboratoriesALKEMNegative -64
USFDA issued warning letter for Daman facility.Rolling sentiment Negative -48
Source
Read the original at CNBC-TV18More Alkem Laboratories news
- Alkem promoters sell shares; funds buy inMoneycontrol · Company update ·
- ICICI Securities retains Buy on Alkem with Rs 6600 targetMoneycontrol · Company update ·
- Alkem Labs Q2 net profit falls 14% to Rs 667 croreMoneycontrol · Results ·
- Alkem shares fall 3% after Q2 results; MOFSL retains Neutral ratingBusiness Standard · Results ·
- Motilal Oswal sets ALKEM target at Rs 5890Moneycontrol · Company update ·